Joseph Edelman

Joseph Edelman

Signal active

CEO & Founder

Bio

Joseph Edelman founded Perceptive Advisors, LLC in 1999, a hedge fund focused on supporting the progress of the life sciences industry. Under Joe’s leadership, Perceptive has grown into one of the largest and most successful life sciences funds with over $2 billion of assets under management by applying thorough due diligence and insights in assessing technologies for investment. The firm oversees a portfolio of investments in various therapeutic areas across all stages of development and commercialization. Perceptive has increasingly led seed and early financing rounds in private life sciences companies from company formation through the development life cycle. Previously, Joe was Senior Analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from 1994 through 1998. Prior to Aries Fund, he was Senior Biotechnology Analyst at Prudential Securities for four years, after starting his career in the healthcare sector of the securities industry as Biotechnology Analyst at Labe, Simpson. Joe earned an MBA from New York University and a BA, magna cum laude, in psychology from the University of California, San Diego.

Location

New York, New York, United States, North America

Social

Primary Organization

Perceptive Advisors

Perceptive Advisors

Founded

1999

Investment

277

Lead investment

95

Exits

144

Employees

11-50

Industry

Financial Services, Venture Capital, Finance

Jobs history

4

Prudential Securities

Senior Biotechnology Analyst

1990 - 1994

New York Genome Center

Board if Directors

Invalid date - Current

Brown University

Board of Trustees

2019 - Current

Athira Pharma

Board Member

2020 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Joseph Edelman is the CEO & Founder at Perceptive Advisors, based in New York, New York, United States, North America. With a background in Financial Services, Joseph Edelman has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

7

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Jul 23, 2019
Frequency Therapeutics Frequency Therapeutics
Series C - Frequency Therapeutics
Frequency Therapeutics Perceptive Advisors
0
Jun 04, 2020
Athira Pharma Athira Pharma
Series B - Athira Pharma
Athira Pharma Perceptive Advisors
85.0M
Jul 17, 2020
Frequency Therapeutics Frequency Therapeutics
Post-IPO Equity - Frequency Therapeutics
Frequency Therapeutics Perceptive Advisors
42.3M
Feb 28, 2024
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
Post-IPO Equity - Crinetics Pharmaceuticals
Crinetics Pharmaceuticals Perceptive Advisors
350.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.